image
Healthcare - Biotechnology - NASDAQ - US
$ 5.84
6.76 %
$ 8.53 M
Market Cap
-0.34
P/E
BALANCE SHEET
39 M ASSETS
-7.18%
3.67 M LIABILITIES
15.32%
35.3 M EQUITY
-9.03%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Forte Biosciences, Inc.
image
Current Assets 38.3 M
Cash & Short-Term Investments 37.1 M
Receivables 0
Other Current Assets 1.2 M
Non-Current Assets 653 K
Long-Term Investments 0
PP&E 109 K
Other Non-Current Assets 544 K
Current Liabilities 3.67 M
Accounts Payable 1.42 M
Short-Term Debt 0
Other Current Liabilities 2.24 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 12.0 41.1 42.0 58.8 6.9 40.8 35.9 5.5 8.2
Short Term Investments 25.2 0 0 0 12.8 55.3 52.8 25.7 50.8
Receivables 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 1.2 0.4 0.5 1.1 0.6 1.7 1.9 1.2 1.3
Total Current Assets 38.3 41.5 42.5 59.9 7.5 97.7 90.6 32.5 60.2
PP&E 0.1 0 0 97 K 0.2 4.0 1.2 0.7 0.4
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.5 0.5 0.8 1.2 0 1.4 0.2 2.1 1.5
Other Assets 0 0 0 0 0 1 1 0 1
Total Assets 39.0 42.0 43.3 61.2 7.7 103.1 92.1 35.4 62.2
LIABILITIES
Accounts Payable 1.4 1.2 0.9 1.2 1.6 78.4 K 2.0 1.7 1.3
Short Term Debt 0 0 0 0 0 0 4.7 7.2 0.6
Other Current Liabilities 2.2 2.0 0.8 1.0 0.3 16.4 10.6 5.4 3.9
Total Current Liabilities 3.7 3.2 1.8 2.3 1.9 16.5 17.3 14.4 5.9
Long Term Debt 0 0 0 0 4.0 26.2 3.6 13.8 16.9
Deferred Tax Income 0 0 0 0 0 0 36 K 0 0
Other Liabilities 0 0 0 0 6.5 2.2 0 0.1 0.2
Total Liabilities 3.7 3.2 1.8 2.3 12.4 44.9 21.0 28.4 23.1
EQUITY
Common Stock 36 K 21 K 15 K 13 K 1 K 23 K 20 K 2 K 2 K
Retained Earnings (118.5) (87.0) (73.2) (51.5) (5.0) (215.9) (166.9) (128.0) (94.5)
Other Accumulative Comprehensive Income/Loss 4 K 0 (43.3) (61.2) 10 K 23 K 34 K (2.4) 58 K
Total Equity 35.3 38.8 41.5 59.0 (4.8) 58.1 71.1 7.0 39.1
Total Liabilities and Equity 39.0 42.0 43.3 61.2 7.7 103.1 92.1 35.4 62.2
SHARES OUTSTANDING
Common Shares Outstanding 31.6 17.4 14.0 7.4 2.1 1.3 1.0 1.3 1.2